MedTrace Logo

Fistula-associated Anal Adenocarcinoma

NCT05381324 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1004

Last updated 2022-05-19

No results posted yet for this study

Summary

The fistula-associated anal adenocarcinoma is rare in patients suffering from anal fistulas. There is only little data available for this patient collective making characterization and management of this disease difficult. Late diagnosis and advanced tumor stage at diagnosis result in poor clinical outcome. It is the purpose of this study to evaluate patients clinically diagnosed with a FAAC and to further perform a histopathological characterization of the available tumor specimen.

Conditions

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-01-01
Primary Completion
2019-12-31
Completion
2022-05-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05381324 on ClinicalTrials.gov